chains of type-IV collagen [1] [2] [3] . The genes of the Background. Alport's syndrome can be diagnosed by a3( IV ) and a4 (IV ) chains are on chromosome 2 in a staining the a5 chain of type IV collagen in kidney head-to-head fashion [4 ], whereas the gene for the biopsy specimens with a monoclonal antibody. Because a5( IV ) chain resides on chromosome X [2 ]. Staining antibodies already established against the a5 chain of these a chains in the kidney and skin basement require denaturation treatment of cryostat sections to membranes (BM ) with monoclonal antibodies has expose their epitopes. To save time and eÂort for made it possible to diagnose Alport's syndrome at the staining, a new epitope-defined monoclonal antibody protein level [5,6 ]. However, the staining procedure whose epitope is initially exposed on the surface of the with these antibodies involves acid-urea treatment, molecule was established.
Introduction deletion and a discontinuous (mosaic) pattern in the epidermal BM of patients with X chromosome-linked Alport's syndrome is a hereditary nephritis caused by Alport's syndrome is of diagnostic value. gene mutation of the a3( IV), a4 (IV ), and a5( IV )
In the present study epitope-defined monoclonal antibodies against the triple-helical domain of the Staining of a2( IV) and a5( IV ) chains 1239 after the sections had been rinsed three times with PBS, they authors [10, 11] , with synthetic peptides as immunowere incubated with a mixture of fluorochrome-conjugated gens. The antibodies were purified with aÃnity columns antibodies for 1 h. After having been washed with PBS, they coupled with the synthetic peptides, and conjugated were mounted and viewed with a Zeiss Axiophot microscope.
with Texas red and fluorescein isothiocyanate (FITC ), Indirect immunofluorescence staining were done as previrespectively. These fluorochrome-conjugated antibod-ously described [10 ] . ies proved useful and reliable in the staining of kidney and skin biopsy specimens for diagnostic purposes.
Results

Subjects and methods
Two monoclonal antibodies were established. H25 was a rat IgG1, k subclass antibody, and specific for the The amino acid sequence of synthetic peptide used for the a2( IV ) chain, and the epitope sequence was determined a2 (IV ) chain was CDTDVKRAVGGDRQEAIQPG in by the multipin-peptide scanning method and found imperfection XIII ( Figure 1) [ 12,13] . That for the a5 ( IV ) to be EAIQP (Table 1 ) (Table 1 ) at the positions of 251-255 located in from cell fusion were screened first with ELISA using the imperfection III ( Figure 1 ). These antibodies could synthetic peptides and then with indirect immunofluorescence stain normal kidney and skin tissues both with and staining of human cryostat sections with and without acid-without acid-urea treatment of the sections, which urea denaturation [10] .
indicates that the epitopes were exposed on the surface Established hybridoma cells were cultured in a modular of the molecule and resistant to denaturation treatminifermenter ( Heraeus Instruments, Osterode, Germany) ment. The staining patterns of H25 and H53 were the to obtain a culture supernatant containing a high concentrasame as those of monoclonal antibody H21 and H22, tion of the antibody. Antibodies were purified with synthetic and H51 and H52 respectively, which were epitopepeptide-coupled aÃnity columns according to the method described previously [ 16 ] . Texas red ( Molecular Probes, Inc., defined and against sequences near the carboxyl terEugene, OR, USA) and FITC (Sigma, St. Louis, MO) were minal of the NC1 domain [10 ] .
conjugated to the purified antibodies [17] . Double immunofluorescence staining using TexasThe epitope of the monoclonal antibody was mapped with red-conjugated H25 and FITC-conjugated H53 was overlapping peptides on the surface of diÂerent rods (multi-carried out with 54 human kidney specimens from pin-peptide scanning method ) [18] . The peptides were custom normal subjects (Figure 2 , A-C ) and patients with ordered from Chiron-Mimotopes, Inc., Australia. non-hereditary nephritis. H25 (anti-a2) stained the Overlapping 10-residue peptides homologous with the endothelial side of the glomerular BM, the tubular sequences of imperfection XIII of the a2( IV ) chain and BM, the Bowman's capsular BM, the mesangial matrix, imperfection III of the a5( IV ) chain were used. and the capillary BM of all specimens. This staining Kidney and skin tissues from human subjects were placed in OCT compound ( Miles Inc., Elkhart, Indiana, USA) and snap-frozen in liquid nitrogen. They were then cut into 4-mm sections in a cryostat and air dried. Chain-specific monoclonal antibodies were raised against synthetic IDVEFQKGDQ 2.397 peptides. The epitopes for H25 and H53 determined by Geysen's DVEFQKGDQG 0.057 multipin-peptide scanning method [18] are shown by underlines. VEFQKGDQGL 0.060 Imperfections are shown by boxes. Fig. 2 . Staining of the a2( IV ) and a5( IV ) chains in kidney and skin. A-C, kidney from a normal subject; D-F, kidney form a male patient with X chromosome-linked Alport syndrome; G-I, skin from a female with X chromosome-linked Alport syndrome. Direct double immunofluorescence staining was used. A, D, G, staining with Texas-red-conjugated H25 for a2( IV ); B, E, H, staining with FITCconjugated H53 for a5( IV); C, F, I, dual exposure of both staining. No staining of the a5( IV ) chain was observed in the glomerular and tubular BMs in the kidney of the male patient ( E). A discontinuous (mosaic) pattern of the a5( IV ) chain was observed in the epidermal BM of the female patient ( H ). ×90.
pattern was the same as that of H21 and of H22. H53 (Figure 2, E ) . Positive staining of the a2 (IV ) chain was observed in the Alport sections, but the staining (anti-a5) stained the glomerular BM, Bowman's capsular BM and the part of the tubular BM of all specimens, of glomerular BM was stronger than that of glomerular BM in the normal kidneys (Figure 2 , D). and this staining pattern was the same as that of H51 and of H52 [9, 10] .
Staining of the a2( IV ) and a5 (IV ) chains in skin tissues from two female patients with X chromosomeStaining of two kidney biopsy specimens from male patients with X chromosome-linked Alport's syndrome linked Alport's syndrome was also done (Figure 2 , G-I ). The antibodies to the a2 (IV ) chain stained the was carried out (Figure 2, D-F ) . Screening for gene mutations in all the exons (1-51) of the COL4A5 gene epidermal and vascular BMs in a linear pattern. This pattern was the same as that seen in the normal skin. of the patients was carried out by PCR-SSCP analysis [19 ] . One patient had a deletion of adenine at nucleo-In contrast, the antibodies against the a5( IV ) chain stained only the epidermal BM in a discontinuous tide 1274 in exon 19 of the COL4A5 gene and the predicted mutation at the protein level was a protein (mosaic) pattern, although the staining was weaker than that stained by indirect staining. This discontinudeletion according to a frameshift. The gene mutation of the other patients was not defined by PCR-SSCP ous pattern is diÂerent from that of the normal skin, where H53 stained the epidermal BM in a continuous analysis. No staining of the a5 (IV ) chain was observed on the glomerular or tubular BMs of both patients pattern.
